Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4205064
Max Phase: Preclinical
Molecular Formula: C13H13N3OS
Molecular Weight: 259.33
Molecule Type: Small molecule
Associated Items:
ID: ALA4205064
Max Phase: Preclinical
Molecular Formula: C13H13N3OS
Molecular Weight: 259.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1ccccc1C1=NC(Cc2c[nH]cn2)CS1
Standard InChI: InChI=1S/C13H13N3OS/c17-12-4-2-1-3-11(12)13-16-10(7-18-13)5-9-6-14-8-15-9/h1-4,6,8,10,17H,5,7H2,(H,14,15)
Standard InChI Key: AGJYNAQBTFSPHI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 259.33 | Molecular Weight (Monoisotopic): 259.0779 | AlogP: 2.22 | #Rotatable Bonds: 3 |
Polar Surface Area: 61.27 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.62 | CX Basic pKa: 6.54 | CX LogP: 2.67 | CX LogD: 2.62 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.89 | Np Likeness Score: 0.71 |
1. Lin Z, Smith MD, Concepcion GP, Haygood MG, Olivera BM, Light A, Schmidt EW.. (2017) Modulating the Serotonin Receptor Spectrum of Pulicatin Natural Products., 80 (8): [PMID:28745513] [10.1021/acs.jnatprod.7b00317] |
Source(1):